Perspectives on models of spinal muscular atrophy for drug discovery

This publication has 20 references indexed in Scilit:

• Identification of a Novel Cyclic AMP-response Element (CRE-II) and the Role of CREB-1 in the cAMP-induced Expression of the Survival Motor Neuron (SMN) Gene
  Journal of Biological Chemistry, 2004
• Valproic acid increases SMN levels in spinal muscular atrophy patient cells
  Annals of Neurology, 2003
• Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
  European Journal of Human Genetics, 2003
• Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
  Human Molecular Genetics, 2003
• Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
  Human Molecular Genetics, 2001
• An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
  Gene Therapy, 2001
• Treatment of spinal muscular atrophy by sodium butyrate
  Proceedings of the National Academy of Sciences, 2001
• Mice, the Motor System, and Human Motor Neuron Pathology
  Mammalian Genome, 2000
• Interferons and IRF-1 Induce Expression of the Survival Motor Neuron (SMN) Genes
  Molecular Medicine, 2000
• Animal models of spinal muscular atrophy
  Human Molecular Genetics, 2000